aiqbench analysis
Siloton has secured £8.4 million in Innovate UK funding to accelerate clinical trials for its GiraffeOCT handheld retinal imaging system, which integrates advanced quantum optical coherence tomography technology. The project aims to deploy both in-clinic and at-home versions of the device to address NHS waiting lists by leveraging a specialized BlueJay chip originally designed for astronaut health monitoring. This initiative represents a significant step toward integrating quantum-enabled diagnostics directly into routine healthcare workflows outside traditional hospital settings.
£8.4 million to bring quantum eye scans to NHS patients

Siloton received £8.4 million from Innovate UK to advance its GiraffeOCT device, bringing quantum technology to NHS retinal imaging.
Innovate UK has awarded Bristol-based med-tech start-up Siloton an £8.4 million contract to accelerate development of its GiraffeOCT handheld eye imaging system. The funding will support the design of both in-clinic and at-home versions of the device, as well as clinical trials, potentially shortening the development timeline by up to two years. Siloton aims to bring advanced retinal imaging outside of traditional hospital settings, addressing an…
Excerpt shown under the publisher's RSS terms · 66 words · full text and figures are on the publisher's site
Related coverage
News Archive 2026
Quantum Computing Report · Jul 25, 2026

Ben Varcoe, The Leeds Physicist and Entrepreneur Behind Creavo and Cavero
Quantum Zeitgeist · Sep 28, 2026

NVIDIA Inception startups tackle gaps in breast cancer care
Quantum Zeitgeist · Oct 6, 2026

Stock Market Today Highlights, Sept 2: Sensex ends 373 pts lower at 76, 570, Nifty below 24, 000; Asian Paints, HDFC Bank fall most
thehindubusinessline.com · Sep 2, 2026